Victory Capital Management
STRO icon

Victory Capital Management’s Sutro Biopharma STRO Stock Holding History

Victory Capital Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,512
Closed -$195K – 2699
2022
Q3 		$195K Sell
3,512
-26
-0.7% -$1.54K ﹤0.01% 2360
2022
Q2 		$184K Buy
3,538
+4
+0.1% +$223 ﹤0.01% 2372
2022
Q1 		$212K Sell
3,534
-13,862
-80% -$1.32M ﹤0.01% 2396
2021
Q4 		$2.59M Buy
17,396
+3,688
+27% +$661K ﹤0.01% 1476
2021
Q3 		$2.59M Sell
13,708
-123
-0.9% -$23.4K ﹤0.01% 1508
2021
Q2 		$2.57M Sell
13,831
-796
-5% -$156K ﹤0.01% 1565
2021
Q1 		$3.33M Buy
14,627
+12
+0.1% +$2.85K ﹤0.01% 1486
2020
Q4 		$3.17M Buy
14,615
+478
+3% +$79.1K ﹤0.01% 1371
2020
Q3 		$1.42M Sell
14,137
-1,974
-12% -$187K ﹤0.01% 1560
2020
Q2 		$1.25M Buy
16,111
+4,247
+36% +$408K ﹤0.01% 1625
2020
Q1 		$1.21M Buy
11,864
+11,498
+3,142% +$1.21M ﹤0.01% 1782
2019
Q4 		$40K Sell
366
-178
-33% -$18.4K ﹤0.01% 2610
2019
Q3 		$49K Buy
544
+178
+49% +$18K ﹤0.01% 2695
2019
Q2 		$42K Sell
366
-234
-39% -$25.8K ﹤0.01% 1755
2019
Q1 		$68K Hold
600
– – ﹤0.01% 1687
2018
Q4 		$54K Hold
600
– – ﹤0.01% 1686
2018
Q3 		$90K Buy
+600
New +$90.6K ﹤0.01% 1676

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Victory Capital Management's STRO Position: Q4 2022 in Review

Victory Capital Management sold out of Sutro Biopharma (STRO) in Q4 2022, closing a stake of 3,512 shares — an estimated $195K sold.

Victory Capital Management first reported a position in STRO in Q3 2018 and held it in 17 quarters. The position peaked at $3.33M in Q1 2021. 118 funds tracked by Wall St. Rank hold STRO as of Q4 2022.

  • Victory Capital Management reported no remaining Sutro Biopharma position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 3,512 Sutro Biopharma shares in Q4 2022, an estimated $195K.
  • Victory Capital Management first reported a position in Sutro Biopharma in Q3 2018 and held it in 17 quarters.
  • Victory Capital Management's Sutro Biopharma position peaked at $3.33M in Q1 2021.
  • 118 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.